<
Ren Guo, director of the Provincial State-owned Assets Supervision and Administration Commission, and his delegation visited Shaanxi Pharmaceutical Group for investigation and guidance
Release time: 2019-03-25     Source: Anonymous

March 21-22,Deputy Secretary of the Party Committee of the Provincial State-owned Assets Supervision and Administration Commission、Director Ren Guo、Deputy Director Sun Ximin、Cui Yuemin, chief engineer of the Provincial Department of Industry and Information Technology, and his party went to Shaanxi Pharmaceutical Group to carry out a two-day research activity with the proposition of revitalizing Shaanxi pharmaceutical industry,Secretary of the Party Committee of Shaanxi Pharmaceutical Stake Sports BettingGroup、Chairman Zhai Riqiang,Deputy Secretary of the Party Committee、General Manager Li Xiqian accompanied the whole process。

The research team successively visited the new and old factories of Xi'an Yangsen, a subsidiary of Shaanxi Pharmaceutical Group、Xi’an Global Printing、Shaanxi Sun Simiao High-tech Pharmaceuticals、TCM Industry Investment Company、Paion Pharmaceuticals and other units,Learn more about the development history of each enterprise、Main products、Scientific research productivity、Later development planning and related situation of traditional Chinese medicine industry,And go deep into the production line of each enterprise to inquire about the production capacity and production operations of each enterprise。

Picture 2.png

Visited and investigated Xi’an Yangsen New Factory

Picture 6.png

Visited and investigated Xi’an Global Printing Company

Picture 11122.png

Visited and investigated Shaanxi Pharmaceutical Holding Paion Pharmaceutical Company

After on-site investigation on March 22,Sun Ximin, deputy director of the Provincial State-owned Assets Supervision and Administration Commission, presided over the symposium,Ren Guo, Director of the Provincial State-owned Assets Supervision and Administration Commission、Feng Lei, Secretary General of Shaanxi Medical Association、Tang Zhishu, Vice President of Shaanxi University of Traditional Chinese Medicine、Su Guofeng, Deputy Director of Xi’an International Port Zone Management Committee、Xu Qizheng, Director of stake online sports bettingAnkang State-owned Assets Supervision and Administration Commission, and all members of the leadership team of Shaanxi Pharmaceutical Group attended the meeting。Secretary of the Party Committee of Shaanxi Pharmaceutical Group、Chairman Zhai Riqiang introduced the overall development of Shaanxi Pharmaceutical Group,Participants focused on the development prospects of Shaanxi’s pharmaceutical industry、Strategic goals and implementation paths were discussed in depth、Communication。

Picture 111223.png

Sun XiminHost a symposium

Director of the Provincial State-owned Assets Supervision and Administration Commission, Ren Guo, passed by Shaanxi Pharmaceutical GroupAlways adhere to openness in 12 years、Cooperation、Fully affirmed the innovative and steady development path,Thinks that the leadership of Shaanxi Pharmaceutical Group is strong。The development of Shaanxi Pharmaceutical GroupforThe development of Shaanxi pharmaceutical industryStronghas made a positive contribution,loseSendTalent,OutputManagementModeAccumulated rich experience to the industryIt serves as a demonstration.

Picture 111224.png

Ren Guo gave a speech

He pointed out,Currently is a period of structural adjustment for the transformation and upgrading of state-owned enterprises in our province,This is a critical period for state-owned enterprises to deepen reforms,Through careful research、Summary,believes that provincial enterprises should adhere to: structural optimization in order to achieve high-quality My stake betting appdevelopment、Good benefits、Innovation driven、Full of energy、Green development。He requested,Shaanxi Pharmaceutical Group must follow the instructions"High-end、Intelligent、Clustering、Integration、Internationalization” standard,Reorganization through integration、Industrial Upgrading、Model innovation、Deepening reforms、Build a platform to build Shaanxi Pharmaceutical Group into a strong pharmaceutical group in the west,Play a leading and leading role in the development of Shaanxi’s pharmaceutical industry。

Deputy Director Sun Ximin made arrangements for the follow-up work related to the survey,The first requirement is to formulate a research report around this research task as soon as possible,Report to the provincial government。The second is to adhere to problem orientation,In-depth researchResearch results, Create conditionsCrack the puzzle, advance questionthoroughlySolution。The third is to strengthen the joint development of Shaanxi Pharmaceutical Group and prefecture-level cities,Make full use of the authentic advantages of southern Shaanxi’s traditional Chinese medicinal materials,Cultivation of Qin Yao brand,Promote the development of Shaanxi’s pharmaceutical industry.